Publication:
Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study

Simple item page
dc.contributor.authorsEraksoy, M.; Akman-Demir, G.; Agan, K.; Gunal, D.; Us, O.; Saip, S.; Demirci, N. O.; Tutuncu, M.; Turan, O. F.; Taskapilioglu, O.; Boz, C.; Terzi, M.; Onar, M.; Aydin-Gungor, H.; Turk-Boru, U.; Soysal, A.; Petek-Balci, B.; Turkoglu, R.; Dib, H.; Siva, A.
dc.date.accessioned2022-03-12T16:01:18Z
dc.date.accessioned2026-01-11T05:57:24Z
dc.date.available2022-03-12T16:01:18Z
dc.date.issued2009
dc.identifier.doi10.1016/S0022-510X(09)70798-1
dc.identifier.issn0022-510X
dc.identifier.urihttps://hdl.handle.net/11424/224843
dc.identifier.wosWOS:000272521300731
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofJOURNAL OF THE NEUROLOGICAL SCIENCES
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEfficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS209
oaire.citation.startPageS209
oaire.citation.titleJOURNAL OF THE NEUROLOGICAL SCIENCES
oaire.citation.volume285

Files

Collections

Araştırma Çıktıları